Related Experiment Videos
[Nitro derivatives: considerations on their antiplatelet activity]
La Clinica Terapeutica
|January 6, 2001
Summary
Nitrates, known for over a century for their antischemic effects, also exhibit antiplatelet properties. This action, linked to increased GMPc, suggests nitrates may improve outcomes in myocardial infarction.
Area of Science:
- Pharmacology and Cardiovascular Medicine
- Nitrate Vasodilators
- Platelet Aggregation Inhibition
Context:
- The antischemic effects of nitrates have been established for over 100 years.
- Emerging research highlights the antiplatelet (antiaggregant) properties of nitrate drugs.
- This antiplatelet action is proposed to be mediated by increased cyclic guanosine monophosphate (cGMP) synthesis.
Purpose:
- To explore the antiaggregant properties of nitrates.
- To investigate the potential role of nitrates in influencing the prognosis of myocardial infarction (MI).
- To compare the potential prognostic impact of nitrates with established MI therapies like beta-blockers, aspirin (ASA), and thrombolytics.
Summary:
- Nitrates demonstrate a dual action: established antischemic effects and newly recognized antiplatelet effects.
- The antiplatelet mechanism is linked to the enhancement of cGMP production.
- These findings suggest nitrates could be considered alongside beta-blockers, ASA, and thrombolytics for managing acute and chronic phases of myocardial infarction.
Impact:
- Re-evaluates the therapeutic role of nitrates in cardiovascular medicine.
- Potentially expands the clinical application of nitrates beyond their traditional antischemic uses.
- May lead to revised treatment guidelines for myocardial infarction, incorporating nitrates as a prognostic modifier.